Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Doxazosin (UK 33274) | 74191-85-8 | 99.9% | C23H25N5O5 | 100 MG
Supplier: Medchemexpress LLC HYB0098100MG
Doxazosin (UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors. It is a long-lasting inhibitor of α1-adrenoceptors, widely used to treat benign prostatic hyperplasia and lower urinary tract symptoms. Doxazosin may also have a direct inhibitory effect on cholesterol synthesis, independent of the LDL receptor, which could lead to an upregulation of the LDL receptor, increasing lipoprotein cholesterol importation and reducing LDL cholesterol in the medium. This product is for research use only and not sold to patients.
- Selectively antagonizes postsynaptic α1-adrenergic receptors.
- Long-lasting α1-adrenoceptor inhibitor.
- Used for benign prostatic hyperplasia and lower urinary tract symptoms.
- Potential to inhibit cholesterol synthesis.
- Effective as monotherapy or in combination with beta-blockers.
- For research use only.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?